—Frederik Balfour, Eye on Asia
As the number of Chinese living in cities explodes, the development opportunities are vast in every field, starting with construction
Not all Web 2.0 applications are advances. Twitter encourages self-absorption and rude behavior in business settings. Pro or con?
"All this for a little pool of capital for LBOs back in 2004. This is the worst hangover ever."
Tell Us: Do You Support the U.S. Federal Reserves Refusal to Cut Rates?
The sovereign wealth funds of the Gulf and Asia eagerly invested in U.S. financials last year. Now the funds are needed, but they are treading with caution
CNET Asia Editors' picks, pans and ratings
With some rivals hindered by global financial turmoil, South Korea's chaebol are expanding fast
When the U.S. brokerage failed, Japanese investors were left holding $1.8 billion of its yen-dominated bonds
Days after the FDA announced a ban on dozens of Ranbaxy drugs, the Indian company says it's seeking advice from Giuliani Partners
The Beijing Olympics brought infrastructure improvements. The 2010 Commonwealth Games could do the same for India, but it won't be easy
India's fifth-largest IT firm says it will make a big-ticket acquisition before 2011—and continue to look at moves in Europe and Japan
Aaron Boesky's Marco Polo fund focuses on Shanghai-listed shares. With the market at a 52-week low, he admits it's not for the faint of heart
Bad news for Ranbaxy, the giant drugmaker and seller of generic drugs in the U.S., as the FDA announced a ban of 30 of its products
Plus: Indian Pharma Ranbaxy Fights FDA Probe
Bank stocks were among the hardest hit in the Japanese market tumble. The shock may make investors and lenders much more risk-averse
Chipmaker SanDisk would bring crucial technologies to the South Korean electronics giant, but how would the move affect the No. 2 Toshiba?
Although many on the list have seen their stocks take a beating, almost all still have robust sales, good margins, and strong market positions